Wang, T., He, M., & Guan, W. (2025). Pyrotinib monotherapy for advanced HER2-positive esophageal adenocarcinoma with trastuzumab resistance and chemotherapy intolerance. Discover Oncology, 16(1), 1. https://doi.org/10.1007/s12672-025-02049-6
Chicago-referens (17:e uppl.)Wang, Tao, Mingyuan He, och Wei Guan. "Pyrotinib Monotherapy for Advanced HER2-positive Esophageal Adenocarcinoma with Trastuzumab Resistance and Chemotherapy Intolerance." Discover Oncology 16, no. 1 (2025): 1. https://doi.org/10.1007/s12672-025-02049-6.
MLA-referens (9:e uppl.)Wang, Tao, et al. "Pyrotinib Monotherapy for Advanced HER2-positive Esophageal Adenocarcinoma with Trastuzumab Resistance and Chemotherapy Intolerance." Discover Oncology, vol. 16, no. 1, 2025, p. 1, https://doi.org/10.1007/s12672-025-02049-6.
